ALOPECIA AREATA
Clinical trials for ALOPECIA AREATA explained in plain language.
Never miss a new study
Get alerted when new ALOPECIA AREATA trials appear
Sign up with your email to follow new studies for ALOPECIA AREATA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New gel takes on bald spots: could methotrexate beat minoxidil?
Disease control Not yet recruitingThis study tests whether a methotrexate gel can regrow hair in people with patchy hair loss (alopecia areata) better than the standard minoxidil spray. About 268 adults will use one of the two treatments for 24 weeks. The goal is to see which works best for reducing bald patches.
Matched conditions: ALOPECIA AREATA
Phase: PHASE4 • Sponsor: Jinnah Postgraduate Medical Centre • Aim: Disease control
Last updated May 26, 2026 08:41 UTC
-
New hope for severe hair loss: drug showdown begins
Disease control Not yet recruitingThis study tests two pills—tofacitinib and methotrexate—against each other in 78 adults with severe alopecia areata, including total scalp and body hair loss. Participants take one of the medicines for 12 weeks, and doctors measure hair regrowth using a standard scoring tool. The…
Matched conditions: ALOPECIA AREATA
Phase: PHASE4 • Sponsor: Hayat Abad Medical Complex, Peshawar • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
Vitamin d cream may offer Needle-Free hair loss treatment
Symptom relief Not yet recruitingThis study tests whether a vitamin D-based cream (calcipotriol) works as well as steroid injections for treating patchy hair loss from alopecia areata. Sixty adults with less than half their scalp affected will use either the cream daily or get injections every few weeks for 12 w…
Matched conditions: ALOPECIA AREATA
Phase: PHASE4 • Sponsor: Hayat Abad Medical Complex, Peshawar • Aim: Symptom relief
Last updated May 22, 2026 13:50 UTC
-
Italian skin disease registry aims to map Real-World treatment patterns
Knowledge-focused Not yet recruitingThis study will look at existing medical records from 20,000 people aged 12 and older in Italy who have psoriasis, atopic dermatitis, vitiligo, alopecia areata, or hidradenitis suppurativa. Researchers want to learn about the types of treatments patients receive, how their diseas…
Matched conditions: ALOPECIA AREATA
Sponsor: Fondazione ISIDE • Aim: Knowledge-focused
Last updated May 18, 2026 12:09 UTC